Hubbell Operating Cash Flow decreased by 80.6% to $86.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 131.6%, from $37.40M to $86.60M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 19.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $150.40M | $97.50M | $206.90M | -$14.40M | $188.60M | $219.60M | $242.40M | $113.70M | $227.70M | $193.90M | $345.50M | $92.20M | $239.60M | $227.00M | $432.40M | $37.40M | $260.60M | $284.30M | $447.50M | $86.60M |
| QoQ Change | — | -35.2% | +112.2% | -107.0% | >999% | +16.4% | +10.4% | -53.1% | +100.3% | -14.8% | +78.2% | -73.3% | +159.9% | -5.3% | +90.5% | -91.4% | +596.8% | +9.1% | +57.4% | -80.6% |
| YoY Change | — | — | — | — | +25.4% | +125.2% | +17.2% | +889.6% | +20.7% | -11.7% | +42.5% | -18.9% | +5.2% | +17.1% | +25.2% | -59.4% | +8.8% | +25.2% | +3.5% | +131.6% |